Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Reiterates a 'Buy' on Allscripts-Misys Healthcare (MDRX); Going Mobile: iPhone App Reduces Barriers to Physician Adoption
-
Notable Analyst Rating Changes 08/03: (MDRX) (GGP) (PCS) Upgraded; (F) (BYD) (BHP) Downgraded
-
Morning Movers 08/03: (CBM) (SIMG) (FIX) (GNET) Higher; (CBR) (KFRC) (EXAM) (KRA) Lower
-
Auriga Upgrades Allscripts-Misys Healthcare (MDRX) to Buy; All Aboard Allscripts (Again!)
-
Notable Analyst Rating Changes 04/07: (HERO) (ELN) (CRM) Upgraded; (MDRX) (CNL) (SSW) Downgraded
-
Auriga Downgrades Allscripts-Misys Healthcare (MDRX) to Hold
-
Auriga Reiterates a 'Buy' on Allscripts-Misys Healthcare (MDRX); Still in the Early Innings; Raises PT
-
Auriga Maintains a 'Buy' Rating on Allscripts-Misys (MDRX); Updating Model to Reflect Eclipsys, Fiscal Year Change

